Financial reports
ARS
2023 FY
Annual report to shareholders
12 Apr 24
10-K
2023 FY
Annual report
12 Mar 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
11 Apr 23
10-K
2022 FY
Annual report
2 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Regulation FD Disclosure
15 Apr 24
8-K
Unregistered Sales of Equity Securities
26 Mar 24
8-K
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
12 Mar 24
8-K
Other Events
4 Jan 24
8-K
Results of Operations and Financial Condition
2 Jan 24
8-K
Regulation FD Disclosure
2 Jan 24
8-K
Regulation FD Disclosure
29 Nov 23
8-K
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
2 Nov 23
8-K
Regulation FD Disclosure
11 Oct 23
8-K
Amendments to Articles of Incorporation or Bylaws
22 Sep 23
Registration and prospectus
S-8
Registration of securities for employees
12 Mar 24
S-3ASR
Automatic shelf registration
12 Mar 24
424B5
Prospectus supplement for primary offering
4 Jan 24
S-3MEF
Registration of additional securities for an S-3
3 Jan 24
424B5
Prospectus supplement for primary offering
2 Jan 24
424B5
Prospectus supplement for primary offering
4 Aug 23
S-3
Shelf registration
4 Aug 23
S-8
Registration of securities for employees
2 Mar 23
424B5
Prospectus supplement for primary offering
8 Feb 23
424B5
Prospectus supplement for primary offering
7 Feb 23
Proxies
DEFA14A
Additional proxy soliciting materials
12 Apr 24
DEF 14A
Definitive proxy
12 Apr 24
PRE 14A
Preliminary proxy
28 Mar 24
DEFA14A
Additional proxy soliciting materials
11 Apr 23
DEF 14A
Definitive proxy
11 Apr 23
DEFA14A
Additional proxy soliciting materials
13 Apr 22
DEF 14A
Definitive proxy
13 Apr 22
Other
EFFECT
Notice of effectiveness
14 Aug 23
CORRESP
Correspondence with SEC
9 Aug 23
UPLOAD
Letter from SEC
8 Aug 23
EFFECT
Notice of effectiveness
12 Oct 22
CORRESP
Correspondence with SEC
5 Oct 22
UPLOAD
Letter from SEC
3 Oct 22
EFFECT
Notice of effectiveness
12 Mar 21
CERT
Certification of approval for exchange listing
12 Mar 21
SEC STAFF
SEC staff action: Order
11 Mar 21
CORRESP
Correspondence with SEC
9 Mar 21
Ownership
SC 13G/A
FMR LLC
11 Mar 24
SC 13G/A
Cormorant Asset Management, LP
14 Feb 24
SC 13G/A
PRICE T ROWE ASSOCIATES INC /MD/
14 Feb 24
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 24
SC 13G/A
HBM Healthcare Investments (Cayman) Ltd.
13 Feb 24
SC 13G/A
Prosight Management, LP
13 Feb 24
4
Randall Kaye
9 Feb 24
4
Brandi Roberts
9 Feb 24
4
Kevin Robert Lind
9 Feb 24
SC 13G/A
FMR LLC
9 Feb 24